# Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS

Study · id `cardio:ct-nct05784051` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05784051](<https://clinicaltrials.gov/study/NCT05784051>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05784051

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 298 participants.

## Technical summary

Registry record NCT05784051. Randomized; no masking; primary purpose prevention. Start 2023-10-01 (anticipated); primary completion 2027-06-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 298 participants (planned count; ClinicalTrials.gov record NCT05784051, source copy `cardio:ctgov-nct05784051-2023-09-06`, retrieved 2026-10-26)
- Planned start: 2023-10-01 (anticipated) (ClinicalTrials.gov record NCT05784051, source copy `cardio:ctgov-nct05784051-2023-09-06`, retrieved 2026-10-26)
- Primary completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT05784051, source copy `cardio:ctgov-nct05784051-2023-09-06`, retrieved 2026-10-26)
- Completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT05784051, source copy `cardio:ctgov-nct05784051-2023-09-06`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05784051-2023-09-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS
- Acronym: SUPPRESS
- Condition: Premature Ventricular Contractions
- Condition: Ventricular Dysfunction, Left
- Intervention (Drug): Experimental group
- Intervention (Drug): Control group
- Lead sponsor: Assistance Publique - Hôpitaux de Paris
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry lists this organization as the lead sponsor: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)

## Provenance

Content hash: 248e5bdaaf821fb0d83fe4c68dca03a8250f3b50b1db071c62a508b5f8ede5e2
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
